We are live on ! Find out more
THC icon

Tenet Healthcare

626 hedge funds and large institutions have $15.2B invested in Tenet Healthcare in 2025 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 192 increasing their positions, 237 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 63

39% more call options, than puts

Call options by funds: $346M | Put options by funds: $249M

29% more funds holding in top 10

Funds holding in top 10: 1418 (+4)

26% more capital invested

Capital invested by funds: $12.1B → $15.2B (+$3.12B)

11% more funds holding

Funds holding: 566626 (+60)

0.83% less ownership

Funds ownership: 94.03%93.2% (-0.83%)

19% less repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 237

Holders
626
Holders Change
+60
Holders Change %
+10.6%
% of All Funds
8.24%
Holding in Top 10
18
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+28.57%
% of All Funds
0.24%
New
126
Increased
192
Reduced
237
Closed
63
Calls
$346M
Puts
$249M
Net Calls
+$97.8M
Net Calls Change
+$17.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Holocene Advisors
26
Holocene Advisors
New York
$103M +$88M +584,404 New
Arrowstreet Capital
27
Arrowstreet Capital
Massachusetts
$102M -$91.5M -607,637 -51%
KCM
28
Khrom Capital Management
Florida
$97.7M +$12.6M +83,700 +18%
Morgan Stanley
29
Morgan Stanley
New York
$93.9M -$12.5M -83,246 -14%
FCM
30
Farallon Capital Management
California
$93.1M +$79.6M +529,000 New
PHS
31
PFM Health Sciences
California
$87.9M +$1.19M +7,909 +2%
Allianz Asset Management
32
Allianz Asset Management
Germany
$87.3M -$3.23M -21,427 -4%
O
33
OrbiMed
New York
$81.8M
Marshall Wace
34
Marshall Wace
United Kingdom
$77.3M +$37M +245,536 +127%
BGDI
35
BW Gestao de Investimentos
Brazil
$75.7M -$15M -99,930 -19%
Allspring Global Investments
36
Allspring Global Investments
North Carolina
$75.7M -$4.01M -26,656 -6%
JP Morgan Chase
37
JP Morgan Chase
New York
$71.6M +$5.75M +38,169 +10%
Citigroup
38
Citigroup
New York
$70.2M +$34.5M +229,351 +135%
UBS AM
39
UBS AM
Illinois
$63.8M +$12.9M +85,664 +31%
Adage Capital Partners
40
Adage Capital Partners
Massachusetts
$62.8M -$16.9M -112,554 -24%
Prudential Financial
41
Prudential Financial
New Jersey
$57M -$22.2M -147,602 -31%
Franklin Resources
42
Franklin Resources
California
$54.1M -$3.44M -22,876 -7%
UBS Group
43
UBS Group
Switzerland
$52.8M -$44.2M -293,312 -49%
SEI Investments
44
SEI Investments
Pennsylvania
$50.8M +$4.16M +27,652 +11%
8KM
45
8 Knots Management
Texas
$48.5M +$41.5M +275,559 New
IHAM
46
Integral Health Asset Management
New York
$48.4M
Wells Fargo
47
Wells Fargo
California
$47.8M +$4.95M +32,916 +14%
First Trust Advisors
48
First Trust Advisors
Illinois
$46.3M -$6.01M -39,927 -13%
Barclays
49
Barclays
United Kingdom
$45.3M +$27.9M +185,265 +257%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$44.2M -$685K -4,549 -2%

THC Hedge Fund Activity: Q2 2025 in Review

626 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Tenet Healthcare (THC) for Q2 2025, worth a combined $15.2B — up 26% from $12.1B a quarter earlier.

Buyers outnumbered sellers: 126 funds opened new THC positions and 63 closed out — a net gain of 63 holders — while 192 added to existing stakes and 237 trimmed.

The largest buyer was Boston Partners, adding an estimated $166M. The largest seller was Invesco, cutting an estimated $205M.

  • 626 institutional investors held Tenet Healthcare (THC) as of Q2 2025, up from 566 in Q1 2025.
  • Funds reported $15.2B of Tenet Healthcare stock for Q2 2025, up 26% quarter-over-quarter.
  • 126 funds opened new Tenet Healthcare positions in Q2 2025 and 63 closed out, a net change of +63 holders.
  • The largest Tenet Healthcare buyer in Q2 2025 was Boston Partners, an estimated $166M added.
  • The largest Tenet Healthcare seller in Q2 2025 was Invesco, an estimated $205M sold.

Based on aggregated 13F filings for Q2 2025.